Creative Biolabs-Immuno-oncology

Anti-GITR (clone 6Z1Gg6Z) SynExpress SV-mKa-IR-Sm Modified CD8+ T cells (CAT#: ITS-1224-CR488)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target GITR (clone 6Z1Gg6Z). We employs the HBV (SV40-mKate-IRF-SmaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
GITR
Clone
6Z1Gg6Z
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
SV40
Effector Gene
IRF
Insertion Sites
SmaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.87
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.